Prevention of Obesity in Antipsychotic, Antidepressant and Antiepileptic Medication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150366852A1
SERIAL NO

14748150

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
N-GENE RESEARCH LABORATORIES INC575 MADISON AVENUE 10TH FLOOR NEW YORK NY

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balogh, Gábor Szeged, HU 12 19
Bernath, Sandor Teiki, HU 6 3
Brownstein, Michael Rockville, US 6 31
Egri, Janos Budapest, HU 15 47
Kolonics, Attila Budapest, HU 10 15
Mandl, József Budapest, HU 3 0
Nagy, Peter Literati Budapest, HU 11 32
Roth, Jesse Whitestone, US 8 21
Sümegi, Balázs Pecs, HU 6 0
Szilvassy, Zoltan Debrecen-Jozsa, HU 9 31
Takács, Kálmán Budapest, HU 3 0
Tory, Kalman Budapest, HU 10 24
Vigh, Laszlo Szeged, HU 15 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation